The proteomics market is entering a period of rapid expansion as healthcare and life sciences organizations increasingly use protein analysis to understand disease mechanisms, identify biomarkers, develop targeted therapies, and advance personalized medicine. The market was valued at USD 38.4 billion in 2025 and is projected to grow from USD 43.7 billion in 2026 to USD 97.7 billion by 2033,...